Linked Life Data

18067923

Source:http://linkedlifedata.com/resource/pubmed/id/18067923

Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:18067923rdf:typepubmed:Citationlld:pubmed
pubmed-article:18067923lifeskim:mentionsumls-concept:C0035820lld:lifeskim
pubmed-article:18067923lifeskim:mentionsumls-concept:C0178784lld:lifeskim
pubmed-article:18067923lifeskim:mentionsumls-concept:C0205054lld:lifeskim
pubmed-article:18067923lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:18067923lifeskim:mentionsumls-concept:C0220825lld:lifeskim
pubmed-article:18067923lifeskim:mentionsumls-concept:C0392756lld:lifeskim
pubmed-article:18067923lifeskim:mentionsumls-concept:C0231491lld:lifeskim
pubmed-article:18067923lifeskim:mentionsumls-concept:C0596235lld:lifeskim
pubmed-article:18067923lifeskim:mentionsumls-concept:C1515655lld:lifeskim
pubmed-article:18067923lifeskim:mentionsumls-concept:C2348480lld:lifeskim
pubmed-article:18067923pubmed:issue1lld:pubmed
pubmed-article:18067923pubmed:dateCreated2008-2-18lld:pubmed
pubmed-article:18067923pubmed:abstractTextWe investigated the organ-reducing ability of 1,2-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-3,5-pyridine-dicarboxylic acid methyl 6-(5-phenyl-3-pyrazolyloxy) hexyl ester (CV159) that exhibits selective blocking of Ca(2+)/calmodulin and inhibition of Ca(2+) overloading in living organisms (Sprague Dawley rats) using an in vivo and an ex vivo electron paramagnetic imaging technique. Decay rates in CV159-treated rats were significantly higher than those in untreated rats and were almost equal to those in the sham group. Both cytosol and mitochondrial superoxide scavenging activity in CV159-treated rats were significantly higher than those in untreated rats, and cytosol superoxide scavenging activity only was slightly higher than that in the sham group. Faint staining for anti-superoxide dismutase antibody was markedly observed in necrotic lesions in the liver of control group. Alanine aminotransferase level in CV-treated rats were significantly decreased as compared with the levels in untreated rats. Electron microscopy showed a decreased number of damaged mitochondria, whereas mitochondrial damage was significantly reduced in CV-treated animals. We conclude that CV159 retains the organ-reducing activity against radicals in hepatic I/R injury that is mediated by the inhibition of Ca(2+) overloading.lld:pubmed
pubmed-article:18067923pubmed:languageenglld:pubmed
pubmed-article:18067923pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18067923pubmed:citationSubsetIMlld:pubmed
pubmed-article:18067923pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18067923pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18067923pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18067923pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18067923pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18067923pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18067923pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:18067923pubmed:statusMEDLINElld:pubmed
pubmed-article:18067923pubmed:monthMarlld:pubmed
pubmed-article:18067923pubmed:issn0022-4804lld:pubmed
pubmed-article:18067923pubmed:authorpubmed-author:KoizumiSatosh...lld:pubmed
pubmed-article:18067923pubmed:authorpubmed-author:NakanoHiroshi...lld:pubmed
pubmed-article:18067923pubmed:authorpubmed-author:AsanoTakayuki...lld:pubmed
pubmed-article:18067923pubmed:authorpubmed-author:AsakuraTakesh...lld:pubmed
pubmed-article:18067923pubmed:authorpubmed-author:KubotaSunaoSlld:pubmed
pubmed-article:18067923pubmed:authorpubmed-author:OtsuboTakehit...lld:pubmed
pubmed-article:18067923pubmed:authorpubmed-author:WatanabeTaiji...lld:pubmed
pubmed-article:18067923pubmed:authorpubmed-author:KamibayashiMa...lld:pubmed
pubmed-article:18067923pubmed:authorpubmed-author:OowadaShigeru...lld:pubmed
pubmed-article:18067923pubmed:authorpubmed-author:IshiuchiAtsuk...lld:pubmed
pubmed-article:18067923pubmed:authorpubmed-author:JinnouchiYuji...lld:pubmed
pubmed-article:18067923pubmed:authorpubmed-author:ShimamuraTsuk...lld:pubmed
pubmed-article:18067923pubmed:authorpubmed-author:KobayashiHiro...lld:pubmed
pubmed-article:18067923pubmed:issnTypePrintlld:pubmed
pubmed-article:18067923pubmed:volume145lld:pubmed
pubmed-article:18067923pubmed:ownerNLMlld:pubmed
pubmed-article:18067923pubmed:authorsCompleteYlld:pubmed
pubmed-article:18067923pubmed:pagination49-56lld:pubmed
pubmed-article:18067923pubmed:dateRevised2009-11-19lld:pubmed
pubmed-article:18067923pubmed:meshHeadingpubmed-meshheading:18067923...lld:pubmed
pubmed-article:18067923pubmed:meshHeadingpubmed-meshheading:18067923...lld:pubmed
pubmed-article:18067923pubmed:meshHeadingpubmed-meshheading:18067923...lld:pubmed
pubmed-article:18067923pubmed:meshHeadingpubmed-meshheading:18067923...lld:pubmed
pubmed-article:18067923pubmed:meshHeadingpubmed-meshheading:18067923...lld:pubmed
pubmed-article:18067923pubmed:meshHeadingpubmed-meshheading:18067923...lld:pubmed
pubmed-article:18067923pubmed:meshHeadingpubmed-meshheading:18067923...lld:pubmed
pubmed-article:18067923pubmed:meshHeadingpubmed-meshheading:18067923...lld:pubmed
pubmed-article:18067923pubmed:meshHeadingpubmed-meshheading:18067923...lld:pubmed
pubmed-article:18067923pubmed:meshHeadingpubmed-meshheading:18067923...lld:pubmed
pubmed-article:18067923pubmed:meshHeadingpubmed-meshheading:18067923...lld:pubmed
pubmed-article:18067923pubmed:meshHeadingpubmed-meshheading:18067923...lld:pubmed
pubmed-article:18067923pubmed:meshHeadingpubmed-meshheading:18067923...lld:pubmed
pubmed-article:18067923pubmed:meshHeadingpubmed-meshheading:18067923...lld:pubmed
pubmed-article:18067923pubmed:meshHeadingpubmed-meshheading:18067923...lld:pubmed
pubmed-article:18067923pubmed:meshHeadingpubmed-meshheading:18067923...lld:pubmed
pubmed-article:18067923pubmed:meshHeadingpubmed-meshheading:18067923...lld:pubmed
pubmed-article:18067923pubmed:year2008lld:pubmed
pubmed-article:18067923pubmed:articleTitleThe role of the new Ca2+ antagonist, CV159, in hepatic I/R injury-the evaluation of hepatic organ reducing activity using in vivo and ex vivo EPR.lld:pubmed
pubmed-article:18067923pubmed:affiliationDepartment of Gastroenterological Surgery, St. Marianna University School of Medicine, Kawasaki, Kanagawa, Japan.lld:pubmed
pubmed-article:18067923pubmed:publicationTypeJournal Articlelld:pubmed